NO941905L - Fremgangsmåte for fremtilling av en prolinboronat-ester - Google Patents
Fremgangsmåte for fremtilling av en prolinboronat-esterInfo
- Publication number
- NO941905L NO941905L NO941905A NO941905A NO941905L NO 941905 L NO941905 L NO 941905L NO 941905 A NO941905 A NO 941905A NO 941905 A NO941905 A NO 941905A NO 941905 L NO941905 L NO 941905L
- Authority
- NO
- Norway
- Prior art keywords
- boronic acid
- protected
- proline
- ester
- esters
- Prior art date
Links
- -1 Proline Boronate Ester Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 4
- IBFLWIOFZGYDFZ-WCCKRBBISA-N OBO.OC(=O)[C@@H]1CCCN1 Chemical compound OBO.OC(=O)[C@@H]1CCCN1 IBFLWIOFZGYDFZ-WCCKRBBISA-N 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- MOILFCKRQFQVFS-BDNRQGISSA-N (1r,3s,4r,5r)-4,6,6-trimethylbicyclo[3.1.1]heptane-3,4-diol Chemical compound C1[C@@H]2C(C)(C)[C@H]1C[C@H](O)[C@@]2(O)C MOILFCKRQFQVFS-BDNRQGISSA-N 0.000 abstract 1
- WADSQZHEAXPENM-UHFFFAOYSA-N 1h-pyrrol-2-ylboronic acid Chemical compound OB(O)C1=CC=CN1 WADSQZHEAXPENM-UHFFFAOYSA-N 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- HISWWEXBLOFKSH-UHFFFAOYSA-N [Li]C1CCCN1 Chemical compound [Li]C1CCCN1 HISWWEXBLOFKSH-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 abstract 1
- 125000005620 boronic acid group Chemical group 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79614891A | 1991-11-22 | 1991-11-22 | |
| US93619892A | 1992-08-26 | 1992-08-26 | |
| PCT/US1992/009845 WO1993010127A1 (en) | 1991-11-22 | 1992-11-19 | Method for making a prolineboronate ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941905D0 NO941905D0 (no) | 1994-05-20 |
| NO941905L true NO941905L (no) | 1994-07-14 |
Family
ID=27121696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941905A NO941905L (no) | 1991-11-22 | 1994-05-20 | Fremgangsmåte for fremtilling av en prolinboronat-ester |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0641347A1 (enExample) |
| JP (1) | JPH07501078A (enExample) |
| CN (1) | CN1073946A (enExample) |
| AU (1) | AU661362B2 (enExample) |
| CA (1) | CA2123128A1 (enExample) |
| CZ (1) | CZ124494A3 (enExample) |
| FI (1) | FI942345A0 (enExample) |
| HU (1) | HUT67937A (enExample) |
| IL (1) | IL103817A0 (enExample) |
| MX (1) | MX9206628A (enExample) |
| NO (1) | NO941905L (enExample) |
| NZ (1) | NZ245207A (enExample) |
| PT (1) | PT101079A (enExample) |
| SI (1) | SI9200332A (enExample) |
| SK (1) | SK59294A3 (enExample) |
| TW (1) | TW232697B (enExample) |
| WO (1) | WO1993010127A1 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6825169B1 (en) | 1991-10-22 | 2004-11-30 | Trustees Of Tufts College | Inhibitors of dipeptidyl-aminopeptidase type IV |
| US5965532A (en) | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US6040145A (en) | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
| US6100234A (en) | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
| JP2001518290A (ja) | 1997-09-29 | 2001-10-16 | ポイント セラピューティクス， インコーポレイテッド | インビトロでの造血細胞の刺激 |
| US6300314B1 (en) | 1998-05-04 | 2001-10-09 | Point Therapeutics, Inc. | Hematopoietic stimulation |
| AU765370B2 (en) | 1998-06-05 | 2003-09-18 | Point Therapeutics, Inc. | Cyclic boroproline compounds |
| US6979697B1 (en) | 1998-08-21 | 2005-12-27 | Point Therapeutics, Inc. | Regulation of substrate activity |
| US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
| WO2001062266A2 (en) * | 2000-02-25 | 2001-08-30 | Novo Nordisk A/S | Use of dpp-iv inhibitors for the treatment of diabetes |
| AU2003218969A1 (en) * | 2002-02-01 | 2003-09-02 | Probiodrug Ag | Modulation of t lymphocytes using dp iv inhibitors |
| US7576121B2 (en) | 2003-11-12 | 2009-08-18 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
| US7317109B2 (en) | 2003-11-12 | 2008-01-08 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
| US7767828B2 (en) | 2003-11-12 | 2010-08-03 | Phenomix Corporation | Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
| AU2004288831B2 (en) * | 2003-11-12 | 2010-08-26 | Phenomix Corporation | Heterocyclic boronic acid compounds |
| JP2007511487A (ja) | 2003-11-17 | 2007-05-10 | ノバルティス アクチエンゲゼルシャフト | ジペプチジルペプチダーゼｉｖ阻害剤の使用 |
| JP5122144B2 (ja) | 2004-01-20 | 2013-01-16 | ノバルティス アーゲー | 直接圧縮製剤および方法 |
| PA8631101A1 (es) * | 2004-04-27 | 2006-09-08 | Wyeth Corp | Proceso de acoplamiento para la generacion de derivados reactivos de pirrol-2-carbonitrilo n-sustituidos con contenido de boro para producir biarilos |
| DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| CA2606785A1 (en) | 2005-05-19 | 2006-11-23 | Genentech, Inc. | Fibroblast activation protein inhibitor compounds and methods |
| US7825139B2 (en) | 2005-05-25 | 2010-11-02 | Forest Laboratories Holdings Limited (BM) | Compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
| CN1331835C (zh) * | 2005-10-18 | 2007-08-15 | 武汉大学 | 光活性β－羟基酮的制备方法 |
| CN101379069A (zh) * | 2005-12-19 | 2009-03-04 | 塔夫茨大学信托人 | 软蛋白酶抑制剂及其前软形式 |
| NZ571110A (en) | 2006-04-11 | 2011-03-31 | Arena Pharm Inc | Methods of using GPR119 receptor to identify Glucose-dependent Insulinotropic Peptide (GIP) secretagogue compounds useful for increasing bone mass in an individual |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| SI2318419T2 (sl) | 2008-06-17 | 2025-10-30 | Takeda Pharmaceutical Company Limited | Spojine boronat estra in njihovi farmacevtski sestavki |
| AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
| JP2013523819A (ja) | 2010-04-06 | 2013-06-17 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置 |
| CN103221410B (zh) | 2010-09-22 | 2017-09-15 | 艾尼纳制药公司 | Gpr119受体调节剂和对与其相关的障碍的治疗 |
| US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
| US9523687B2 (en) | 2014-02-28 | 2016-12-20 | Institut Pasteur | Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS |
| UA121389C2 (uk) | 2014-05-20 | 2020-05-25 | Мілленніум Фармасьютікалз, Інк. | Борвмісні інгібітори протеасом для застосування після первинної протиракової терапії |
| CN107683135A (zh) | 2015-03-09 | 2018-02-09 | 因特克林医疗有限公司 | 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法 |
| WO2018162722A1 (en) | 2017-03-09 | 2018-09-13 | Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke | Dpp-4 inhibitors for use in treating bone fractures |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
| CN108047257B (zh) * | 2017-12-17 | 2020-03-13 | 沧州普瑞东方科技有限公司 | 一种手性n-boc-吡咯烷-2-硼酸的制备工艺 |
| ES2929196T3 (es) * | 2018-02-20 | 2022-11-25 | Otsuka Pharma Co Ltd | Método de producción de 4-boronofenilalanina |
| CN110452258B (zh) * | 2019-09-03 | 2021-01-01 | 上海馨远医药科技有限公司 | 一种二肽缬氨酸硼脯氨酸盐的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935493A (en) * | 1987-10-06 | 1990-06-19 | E. I. Du Pont De Nemours And Company | Protease inhibitors |
| EP0528858B1 (en) * | 1990-04-14 | 1997-01-22 | New England Medical Center Hospitals, Inc. | Inhibitors of dipeptidyl-aminopeptidase type iv |
| GB9017694D0 (en) * | 1990-08-13 | 1990-09-26 | Sandoz Ltd | Improvements in or relating to organic chemistry |
-
1992
- 1992-11-18 MX MX9206628A patent/MX9206628A/es unknown
- 1992-11-19 WO PCT/US1992/009845 patent/WO1993010127A1/en not_active Ceased
- 1992-11-19 HU HU9401350A patent/HUT67937A/hu unknown
- 1992-11-19 AU AU31368/93A patent/AU661362B2/en not_active Expired - Fee Related
- 1992-11-19 PT PT101079A patent/PT101079A/pt not_active Application Discontinuation
- 1992-11-19 SI SI19929200332A patent/SI9200332A/sl unknown
- 1992-11-19 CA CA002123128A patent/CA2123128A1/en not_active Abandoned
- 1992-11-19 EP EP92925238A patent/EP0641347A1/en not_active Withdrawn
- 1992-11-19 CZ CZ941244A patent/CZ124494A3/cs unknown
- 1992-11-19 JP JP5509442A patent/JPH07501078A/ja active Pending
- 1992-11-19 SK SK592-94A patent/SK59294A3/sk unknown
- 1992-11-20 NZ NZ24520792A patent/NZ245207A/en unknown
- 1992-11-20 IL IL103817A patent/IL103817A0/xx unknown
- 1992-11-20 TW TW081109304A patent/TW232697B/zh active
- 1992-11-23 CN CN92113215A patent/CN1073946A/zh active Pending
-
1994
- 1994-05-20 FI FI942345A patent/FI942345A0/fi not_active Application Discontinuation
- 1994-05-20 NO NO941905A patent/NO941905L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI9200332A (en) | 1993-06-30 |
| JPH07501078A (ja) | 1995-02-02 |
| HU9401350D0 (en) | 1994-08-29 |
| WO1993010127A1 (en) | 1993-05-27 |
| NO941905D0 (no) | 1994-05-20 |
| CA2123128A1 (en) | 1993-05-27 |
| CZ124494A3 (en) | 1995-07-12 |
| CN1073946A (zh) | 1993-07-07 |
| HUT67937A (en) | 1995-05-29 |
| SK59294A3 (en) | 1995-02-08 |
| MX9206628A (es) | 1993-05-01 |
| NZ245207A (en) | 1994-07-26 |
| AU3136893A (en) | 1993-06-15 |
| TW232697B (enExample) | 1994-10-21 |
| FI942345A7 (fi) | 1994-05-20 |
| PT101079A (pt) | 1994-02-28 |
| FI942345A0 (fi) | 1994-05-20 |
| EP0641347A1 (en) | 1995-03-08 |
| IL103817A0 (en) | 1993-04-04 |
| AU661362B2 (en) | 1995-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100939598B1 (ko) | 붕소산 에스테르와 산 화합물의 합성 | |
| SK59294A3 (en) | Method of making a prolineboronate ester | |
| Snow et al. | Boronic acid inhibitors of dipeptidyl peptidase IV: A new class of immunosuppressive agents | |
| HK40066099B (en) | Synthesis of boronic ester and acid compounds | |
| HK40066099A (en) | Synthesis of boronic ester and acid compounds | |
| AU2018200981A1 (en) | Synthesis of boronic ester and acid compounds | |
| AU2011265442B2 (en) | Synthesis of boronic ester and acid compounds | |
| MXPA06011276A (en) | Synthesis of boronic ester and acid compounds | |
| HK1100004B (en) | Synthesis of boronic ester and acid compounds | |
| HK1163106A (en) | Synthesis of bortezomib | |
| AU2013202996A1 (en) | Synthesis of boronic ester and acid compounds | |
| HK1164320B (en) | Synthesis of bortezomib |